Protocol Number: 02-AT-0172

Title:

A Randomized Study of Electroacupuncture Treatment for Delayed Chemotherapy-Induced Nausea and Vomiting in Patients with Pediatric Solid Tumors

Number:

02-AT-0172

Summary:

This study will examine the effectiveness of electroacupuncture in treating delayed nausea and vomiting after receiving chemotherapy for pediatric solid tumors. Studies have shown that acupuncture can help lessen nausea and vomiting on the days of chemotherapy, but delayed nausea and vomiting, occurring 1 to 5 days after chemotherapy, is sometimes more difficult to treat. Electroacupuncture, in which a small electric current is passed through the acupuncture needles, may provide a stronger effect than regular acupuncture, and lessen delayed nausea and vomiting.

Patients between 10 and 35 years of age with a newly diagnosed pediatric solid tumor who have not been treated with chemotherapy and have not previously had acupuncture may be eligible for this study.

Sponsoring Institute:

National Center for Complementary and Alternative Medicine (NCCAM)

Recruitment Detail

Type: Completed Study; data analyses ongoing

Gender: Male & Female

Referral Letter Required: No

Population Exclusion(s): None

Eligibility Criteria: This study is not currently recruiting new subjects. If you have questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.

Special Instructions:

Currently Not Provided

Keyword(s):

Quality of Life

Stress

Sham Acupuncture

Acupuncture Points

Cancer Pain

Chemotherapy

Nausea and Vomiting

Recruitment Keyword(s):

Acupuncture

Cancer

Pediatric Sarcoma

Condition(s):

Pediatric Sarcoma

Investigational Drug(s):

None

Investigational Device(s):

None

Interventions:

Procedure/Surgery: Electroacupuncture

Supporting Site:

National Center for Complementary and Alternative Medicine

Contact(s):

This study is not currently recruiting new subjects. If you have questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.

Citation(s):

Latreille J, Pater J, etc Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy National Cancer Instituteof Canada Clinical Trials Group J Clin Oncol 1998 Mar;16(3):1174-8

Morrow GR, Hickok JT, Burish TG, Rosenthal SN Frequency and clinical implications of delayed nausea and delayed emesisAm J Clin Oncol 1996 Apr;19(2):199-203

Stewart DA, Gyonyor E High-dose melphalan +/- total body irradiation and autologous hematopoietic stemcell rescue for adult patients with Ewing's sarcoma or peripheralneuroectodermal tumorBone Marrow Transplant 1996 Aug;18(2):315-8

• Questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
• Technical questions regarding the Clinical Center web site, please contact the Department Clinical Research Informatics, CC.

Search The Studies | Help | Questions |
Clinical Center Home | NIH Home

National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/30/2009